• Building an Innovative Life Sciences Company' CEO Mark Duxon talks at the next OBN digital event 12th May 1pm-2pm, see news page.
  • CEO Mark Duxon interviewed by The Pharma Letter on impact of Brexit on CROs...
  • Announcing new premises in Poland with a focus on neuropsychiatric disorders...
  • State-of-the-art premises opening this month at Discovery Park in Kent...
  • Newly published work in Frontiers in Psychiatry demonstrating
  • the effectiveness of a clinically relevant dose of ketamine...
  • Head to 2021 conferences page to see titles of abstracts...

News you can use

Thanks for your interest in Transpharmation Ltd. We'd like to keep you updated on what's new and relevant. Please sign up to receive our newsletters, we won't bombard you or share your details with any other party and you can unsubscribe at any time.

Announcing Transpharmation Poland! Sent on 08 February 2020

The future's bright for the magic mushroom.

Expansion to world class premises Sent on 04 November 2020

We are delighted to share our very exciting news with you!In January 2021, Transpharmation Ltd will be taking on additional laboratory and office space, operating from the first-class facilities at the renowned Discovery Park research centre in Kent.This location will become Transpharmation’s primary site.

Multiple therapeutic indications Sent on 05 October 2020

Transpharmation Ltd celebrate 10 years in business. See our latest neuroinflammation study being presented at the Annual Alzheimer's Drug Discovery Foundation conference.

Focus on pain Sent on 04 September 2020

September is pain awareness month and we are presenting our latest pain study 'The effect of a reduced streptozocin dose and social housing on well-being, mechanical hypersensitivity and burrowing behaviour in type-1 diabetic rodents' at the IASP virtual conference.

Getting back out there safely Sent on 04 August 2020
New service - PBMC's Sent on 11 March 2020
Display #
Results 1 - 8 out of 8

Start a Conversation

preclinical +44 (0)203 633 2807

clinical trials +353 (0)1896 42 60

clinical research +48 515 244 120

EEG contact@transpharmation.co.uk


Copyright © 2021 Transpharmation Ltd. All Rights Reserved.

Copyright © 2019 Transpharmation Ltd. All Rights Reserved. Website created by Identity Ipswich Web Design